Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.
Condition(s):Major Depressive DisorderLast Updated:May 12, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Major Depressive DisorderLast Updated:May 12, 2022Completed
Condition(s):NarcolepsyLast Updated:January 9, 2024Completed
Condition(s):Idiopathic Hypersomnia; NarcolepsyLast Updated:February 28, 2024Recruiting
Condition(s):Plastic Surgery; Reconstructive SurgeryLast Updated:February 4, 2022Completed
Condition(s):Abdominal Wall Defect; Abdominal Wall Hernia; Eventration; Evisceration; Operation WoundLast Updated:January 13, 2021Unknown status
Condition(s):Ventral HerniaLast Updated:June 22, 2023Withdrawn
Condition(s):Pregnancy Related; NarcolepsyLast Updated:January 25, 2024Recruiting
Condition(s):Hernia; Hernia, Abdominal; Hernia, IncisionalLast Updated:September 25, 2020Completed
Condition(s):Open Midline LaparotomyLast Updated:September 8, 2023Recruiting
Condition(s):Ileostomy – Stoma; Inflammatory Bowel DiseasesLast Updated:July 17, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.